Literature DB >> 20463275

Hyperbaric oxygen therapy and diabetic foot ulcers: knowledge and attitudes of Canadian primary care physicians.

A Wayne Evans1, Richard Gill, Aurelia O Valiulis, Wendy Lou, Ted S Sosiak.   

Abstract

OBJECTIVE: To explore physicians' knowledge of and attitudes toward hyperbaric oxygen therapy (HBOT) in order to better understand current diabetic foot ulcer management practices and to determine potential barriers to HBOT use.
DESIGN: A 24-item questionnaire.
SETTING: Primary Care Today conference in Toronto, Ont, in May of 2006. PARTICIPANTS: Physician attendees, 313 of whom completed the survey. MAIN OUTCOME MEASURES: Self-reported knowledge of and attitudes toward HBOT.
RESULTS: Less than 10% of respondents had a good knowledge of HBOT, but 57% had a good attitude toward HBOT. Knowledge of and attitude toward HBOT were positively correlated (P < .0001). Good knowledge of HBOT was associated with sex (P = .0334), age younger than 40 years (P = .0803), years in medical practice (P = .0646), patient requests for HBOT referrals (P = .0127), and having previously referred patients for HBOT (P < .001). Twenty years or more in medical practice (P = .0593) and receiving patient requests for HBOT (P = .0394) were multivariate predictors of having good knowledge of HBOT. Good attitude toward HBOT was associated with age younger than 40 years (P = .0613) and having previously referred patients for HBOT (P = .0013). Multivariate analysis showed that male physicians (P = .0026) received more patient requests for HBOT (P < .0001), had good knowledge (P = .0129) and a good attitude (P = .0488), and were more likely to refer patients for HBOT.
CONCLUSION: Primary care physicians have underdeveloped knowledge of HBOT, but their generally positive attitudes toward its use suggest that they might be receptive to educational interventions. Educating both physicians and patients about HBOT, specifically its cost-effectiveness, might encourage future use.

Entities:  

Mesh:

Year:  2010        PMID: 20463275      PMCID: PMC2868617     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  15 in total

1.  Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.

Authors:  H Pham; D G Armstrong; C Harvey; L B Harkless; J M Giurini; A Veves
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

2.  The fate of the second leg in the diabetic amputee.

Authors:  M G GOLDNER
Journal:  Diabetes       Date:  1960 Mar-Apr       Impact factor: 9.461

Review 3.  Diabetic foot infections.

Authors:  R G Frykberg; A Veves
Journal:  Diabetes Metab Rev       Date:  1996-10

4.  Lower-extremity amputation in people with diabetes. Epidemiology and prevention.

Authors:  D E Bild; J V Selby; P Sinnock; W S Browner; P Braveman; J A Showstack
Journal:  Diabetes Care       Date:  1989-01       Impact factor: 19.112

5.  The later life of the diabetic amputee. Another look at fate of the second leg.

Authors:  F W Whitehouse; C Jurgensen; M A Block
Journal:  Diabetes       Date:  1968-08       Impact factor: 9.461

6.  Physician adoption of hyperbaric oxygen therapy in the treatment of chronic wounds.

Authors:  Shien Guo; Michael A Counte; Homer Schmitz; Horng-Shiuann Wu
Journal:  Ostomy Wound Manage       Date:  2005-10       Impact factor: 2.629

7.  Lower-extremity amputation. Incidence, risk factors, and mortality in the Oklahoma Indian Diabetes Study.

Authors:  J S Lee; M Lu; V S Lee; D Russell; C Bahr; E T Lee
Journal:  Diabetes       Date:  1993-06       Impact factor: 9.461

8.  Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers.

Authors:  Anderson W Chuck; David Hailey; Philip Jacobs; Douglas C Perry
Journal:  Int J Technol Assess Health Care       Date:  2008       Impact factor: 2.188

9.  The epidemiology of lower extremity amputations in diabetic individuals.

Authors:  R S Most; P Sinnock
Journal:  Diabetes Care       Date:  1983 Jan-Feb       Impact factor: 19.112

10.  Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo.

Authors:  Tatyana N Milovanova; Veena M Bhopale; Elena M Sorokina; Jonni S Moore; Thomas K Hunt; Martin Hauer-Jensen; Omaida C Velazquez; Stephen R Thom
Journal:  J Appl Physiol (1985)       Date:  2008-11-20
View more
  1 in total

1.  Hyperbaric oxygen therapy for late radiation tissue injury in gynecologic malignancies.

Authors:  P Craighead; M A Shea-Budgell; J Nation; R Esmail; A W Evans; M Parliament; T K Oliver; N A Hagen
Journal:  Curr Oncol       Date:  2011-10       Impact factor: 3.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.